proxyvotesnow.com

Home › Companies › VAXCYTE INC. › 2023-2024

VAXCYTE INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and VAXCYTE INC.’s Form 8-K, filed 2024-06-10 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 5Ballot items
  • 301Asset managers
  • 2,466Fund votes
  • 2024-06-06Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore VAXCYTE INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by VAXCYTE INC.

These tallies are VAXCYTE INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-10 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

VAXCYTE INC. — official shareholder meeting results, meeting held 2024-06-06
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Annie Drapeau 82,886,170---- 16,143,5824,817,013 Majority: yes
Elect Director: Teri Loxam 96,840,846---- 2,188,9064,817,013 Majority: yes
Elect Director: Carlos Paya, M.D., Ph.D. 96,685,408---- 2,344,3444,817,013 Majority: yes
Proposal 2: The ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. The appointment was ratified by the votes indicated: 103,807,99314,74524,027 ---- Majority: yes
Proposal 3: The approval, on a non-binding, advisory basis of the compensation of the Company's named executive officers. The approval of the non-binding resolution on named executive officer compensation was approved by the votes indicated: 91,072,2697,934,24823,235 --4,817,013 Majority: yes

Source: VAXCYTE INC., Form 8-K, filed with the SEC on 2024-06-10 — read the filing on EDGAR.

How asset managers voted at the VAXCYTE INC. 2023-2024 meeting

Each item below shows how the 301 asset managers that disclosed a VAXCYTE INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 12 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%8%
FOR: 91,072,269AGAINST: 7,934,248

VAXCYTE INC.’s own tally for this item (“Proposal 3: The approval, on a non-binding, advisory basis of the compensation of the Company's named executive officers. The approval of the non-binding resolution on named executive officer compensation was approved by”): 91,072,269 for, 7,934,248 against, per its Form 8-K filed 2024-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 108,755,731 outstanding shares: 84% for, 7% against (91% of the company cast a for/against vote).

The 301 asset managers below cast 90% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR 89%10%
FOR: 89.4%AGAINST: 10.0%ABSTAIN: 0.5%1 YEAR: 0.1%NOT VOTED: 0.0%
Largest asset managers voting on “Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.” at VAXCYTE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity28,179,0720 00For
Vanguard12,375,9050 00For
T. Rowe Price11,020,6550 00For
Janus Henderson7,490,8080 00For
BlackRock7,326,00610,058 00For
RA CAPITAL MANAGEMENT, L.P.6,212,8740 00For
JANUS INVESTMENT FUND4,824,4570 00For
Wellington4,552,9130 00For
State Street4,137,6435,141 00For
Capital Research Global Investors04,140,113 00Against
Capital Group583,719,065 00Against
AllianceBernstein2,270,4860 00For
FRANKLIN ADVISERS INC1,883,8100 00For
JPMorgan1,853,6530 00For
Charles Schwab1,689,8310 00For
Invesco01,380,448 00Against
FRED ALGER MANAGEMENT, LLC60,6621,239,173 00Against
GEODE CAPITAL MANAGEMENT, LLC1,245,2050 00For
DRIEHAUS CAPITAL MANAGEMENT LLC1,158,9120 00For
WESTFIELD CAPITAL MANAGEMENT CO LP1,040,52150,001 00For
JENNISON ASSOCIATES LLC1,071,2522,276 00For
ORBIMED ADVISORS LLC1,034,6920 00For
FRANKLIN STRATEGIC SERIES911,6020 00For
COMMODORE CAPITAL LP860,0000 00For
Federated Hermes851,5000 00For

Showing the 25 largest of 301 asset managers. See all 301 in the interactive database.

2. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 103,807,993AGAINST: 14,745

VAXCYTE INC.’s own tally for this item (“Proposal 2: The ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. The appointment was ratified by the vo”): 103,807,993 for, 14,745 against, per its Form 8-K filed 2024-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 108,755,731 outstanding shares: 95% for, 0.1% against (95% of the company cast a for/against vote).

The 108 asset managers below cast 99.9% of the shares they voted on this item FOR (58,662,586 for, 6,241 against).

FOR 99.9%
FOR: 58,662,586 (100.0%)AGAINST: 6,241 (0.0%)ABSTAIN: 20,481 (0.0%)
Largest asset managers voting on “Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accoun” at VAXCYTE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity12,912,3820 00For
Vanguard12,083,2780 00For
JANUS INVESTMENT FUND4,824,4570 00For
T. Rowe Price4,492,3370 00For
BlackRock4,344,9590 00For
Capital Group3,719,0650 00For
State Street1,105,8890 00For
FRANKLIN STRATEGIC SERIES911,6020 00For
JPMorgan876,1110 00For
Charles Schwab835,4230 00For
MUTUAL FUND SERIES TRUST657,2060 00For
Prudential/PGIM648,5590 00For
AllianceBernstein633,0680 00For
Invesco614,8530 00For
Equitable525,7070 00For
Bridge Builder Trust502,8840 00For
Federated Hermes425,7500 00For
HARBOR FUNDS411,8010 00For
American Century404,2400 00For
Jackson National403,9530 00For
NEW ECONOMY FUND396,4830 00For
Hartford386,4240 00For
ALGER INSTITUTIONAL FUNDS360,8950 00For
AB DISCOVERY GROWTH FUND, INC.314,9550 00For
Lord Abbett305,3550 00For

Showing the 25 largest of 108 asset managers. See all 108 in the interactive database.

3. Election of Class I Directors Nominees would serve until the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Annie Drapeau

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

84% Majority: yes · of votes cast

FOR 84%WITHHELD 16%
FOR: 82,886,170WITHHELD: 16,143,582

VAXCYTE INC.’s own tally for this item (“Elect Director: Annie Drapeau”): 82,886,170 for, 16,143,582 withheld, per its Form 8-K filed 2024-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 108,755,731 outstanding shares: 76% for, 15% withheld (91% of the company cast a for/withheld vote).

The 107 asset managers below cast 99.9% of the shares they voted on this item FOR (50,146,931 for, 72 against).

FOR 85%ABSTAIN 15%
FOR: 50,146,931 (85.4%)AGAINST: 72 (0.0%)ABSTAIN: 8,541,549 (14.6%)
Largest asset managers voting on “Election of Class I Directors Nominees would serve until the 2027 Annual Meeting of Stockholders and until the” at VAXCYTE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity12,891,8030 20,5790For
Vanguard12,083,2780 00For
JANUS INVESTMENT FUND3,891,1730 933,2840For
T. Rowe Price4,492,3370 00For
BlackRock4,344,9590 00For
Capital Group3,719,0650 00For
State Street1,066,7690 39,1200For
FRANKLIN STRATEGIC SERIES911,6020 00For
JPMorgan876,1110 00For
Charles Schwab835,4230 00For
MUTUAL FUND SERIES TRUST657,2060 00For
Prudential/PGIM644,8620 3,6970For
AllianceBernstein00 633,0680Abstain
Invesco00 614,8530Abstain
Equitable291,5880 234,1190For
Bridge Builder Trust19,7640 483,1200Abstain
Federated Hermes425,7500 00For
HARBOR FUNDS00 411,8010Abstain
American Century00 404,2400Abstain
Jackson National117,5920 286,3610Abstain
NEW ECONOMY FUND396,4830 00For
Hartford386,4240 00For
ALGER INSTITUTIONAL FUNDS00 360,8950Abstain
AB DISCOVERY GROWTH FUND, INC.00 314,9550Abstain
Lord Abbett00 305,3550Abstain

Showing the 25 largest of 107 asset managers. See all 107 in the interactive database.

4. Election of Class I Directors Nominees would serve until the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Carlos Paya, M.D., Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 96,685,408WITHHELD: 2,344,344

VAXCYTE INC.’s own tally for this item (“Elect Director: Carlos Paya, M.D., Ph.D.”): 96,685,408 for, 2,344,344 withheld, per its Form 8-K filed 2024-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 108,755,731 outstanding shares: 89% for, 2% withheld (91% of the company cast a for/withheld vote).

The 107 asset managers below cast 100% of the shares they voted on this item FOR (57,299,312 for, 0 against).

FOR 98%
FOR: 57,299,312 (97.6%)ABSTAIN: 1,389,240 (2.4%)
Largest asset managers voting on “Election of Class I Directors Nominees would serve until the 2027 Annual Meeting of Stockholders and until the” at VAXCYTE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity12,891,8030 20,5790For
Vanguard12,083,2780 00For
JANUS INVESTMENT FUND4,824,4570 00For
T. Rowe Price4,492,3370 00For
BlackRock4,344,9590 00For
Capital Group3,719,0650 00For
State Street1,104,7150 1,1740For
FRANKLIN STRATEGIC SERIES911,6020 00For
JPMorgan876,1110 00For
Charles Schwab835,4230 00For
MUTUAL FUND SERIES TRUST657,2060 00For
Prudential/PGIM648,5590 00For
AllianceBernstein00 633,0680Abstain
Invesco614,8530 00For
Equitable291,5880 234,1190For
Bridge Builder Trust502,8840 00For
Federated Hermes425,7500 00For
HARBOR FUNDS411,8010 00For
American Century404,2400 00For
Jackson National403,9530 00For
NEW ECONOMY FUND396,4830 00For
Hartford386,4240 00For
ALGER INSTITUTIONAL FUNDS360,8950 00For
AB DISCOVERY GROWTH FUND, INC.00 314,9550Abstain
Lord Abbett305,3550 00For

Showing the 25 largest of 107 asset managers. See all 107 in the interactive database.

5. Election of Class I Directors Nominees would serve until the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Teri Loxam

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 96,840,846WITHHELD: 2,188,906

VAXCYTE INC.’s own tally for this item (“Elect Director: Teri Loxam”): 96,840,846 for, 2,188,906 withheld, per its Form 8-K filed 2024-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 108,755,731 outstanding shares: 89% for, 2% withheld (91% of the company cast a for/withheld vote).

The 107 asset managers below cast 100% of the shares they voted on this item FOR (57,309,857 for, 0 against).

FOR 98%
FOR: 57,309,857 (97.7%)ABSTAIN: 1,378,695 (2.3%)
Largest asset managers voting on “Election of Class I Directors Nominees would serve until the 2027 Annual Meeting of Stockholders and until the” at VAXCYTE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity12,891,8030 20,5790For
Vanguard12,083,2780 00For
JANUS INVESTMENT FUND4,824,4570 00For
T. Rowe Price4,492,3370 00For
BlackRock4,344,9590 00For
Capital Group3,719,0650 00For
State Street1,104,7150 1,1740For
FRANKLIN STRATEGIC SERIES911,6020 00For
JPMorgan876,1110 00For
Charles Schwab835,4230 00For
MUTUAL FUND SERIES TRUST657,2060 00For
Prudential/PGIM648,5590 00For
AllianceBernstein00 633,0680Abstain
Invesco614,8530 00For
Equitable291,5880 234,1190For
Bridge Builder Trust502,8840 00For
Federated Hermes425,7500 00For
HARBOR FUNDS411,8010 00For
American Century404,2400 00For
Jackson National403,9530 00For
NEW ECONOMY FUND396,4830 00For
Hartford386,4240 00For
ALGER INSTITUTIONAL FUNDS360,8950 00For
AB DISCOVERY GROWTH FUND, INC.00 314,9550Abstain
Lord Abbett305,3550 00For

Showing the 25 largest of 107 asset managers. See all 107 in the interactive database.

Largest VAXCYTE INC. shareholders voting in 2023-2024

Ranked by the number of VAXCYTE INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 108,755,731 shares outstanding at the time of that meeting.

Top VAXCYTE INC. shareholders by shares voted, 2023-2024
#Asset manager % of shares outstanding
1Fidelity 25.91%
2Vanguard 11.38%
3T. Rowe Price 10.13%
4Janus Henderson 6.89%
5BlackRock 6.75%
6RA CAPITAL MANAGEMENT, L.P. 5.71%
7JANUS INVESTMENT FUND 4.44%
8Wellington 4.19%
9State Street 3.81%
10Capital Research Global Investors 3.81%

Reported VAXCYTE INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

VAXCYTE INC. beneficial owners on record for the 2023-2024 proxy season
Holder % outstanding Disclosure
FMR LLC 13.07% DEF14A
FMR (Fidelity) 11.50% 13F
Vanguard Group 11.33% 13F
BlackRock 9.15% 13F
RA Capital Management, L.P. 8.91% DEF14A
Janus Henderson Group plc 6.42% DEF14A
State Street 3.07% 13F
T. Rowe Price 2.92% 13F
Geode Capital 2.10% 13F
Franklin Templeton 1.97% 13F

Percentages above are of 108,755,731 shares outstanding, as reported by VAXCYTE INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from VAXCYTE INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At VAXCYTE INC.'s shareholder meeting held 2024-06-06, in the 2023-2024 proxy season, 301 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 2,466 separate fund positions. On the most widely held item on that ballot — Approval, on a non-binding, advisory basis, of the compensation of the Company's named… — FOR was 92% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: VAXCYTE INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-10.

VAXCYTE INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.